Cerebral Palsy, Child Development Disorders, Preterm Infant
Conditions
Keywords
preterm, Child Development Disorders, Hammersmith, neurological outcomes, epidemiology
Brief summary
In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice
Detailed description
The primary aim of this study is to evaluate the neurobehavioural performance of infants born preterm using the Hammersmith Infant Neurological Examination (HINE) in standard medical practice and compare it with the gold standard MRI and ultrasound imagings. It would be possible to check do we need to use all the 3 examinations or Hammersmith examination would be enough reliable predictor. Secondary aim is to explore the relationships between MRI brain /cranial us abnormalities and HINE at term-equivalent age in infants born preterm in prediction of neurological outcome at 1 year of chronological age. This study will be only single arm/single group. This group would receive the regular practice of MRI, Ultrasound (US) and Hammersmith assessments. The 3 assessments would be compared in relationships with the neonatal developmental outcomes (developmental milestones).
Interventions
OTHERCorrelation analyses for the outcomes
No medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound
Sponsors
Abha International Private Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Preterm infants \<37 weeks' GA at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants \<37weeks at birth over a 1-year stating from march 2018
Exclusion criteria
* -infants with congenital or chromosomal abnormalities
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Non inferiority of MRI to Hammersmith assessments in developmental outcomes | 12 month | Hammersmith assessment will be tested for non-inferiority to gold standard assessment method by MRI in terms of sensitivity for early prediction of delayed neurological syndrome (DNS) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hammersmith health economic analyses if primary endpoint is achieved | 12 month | Both cost minimization analyses and cost effective analyses would be applied |
| Superiority testing for Hammersmith assessment to gold standard MRI | 12 month | Testing the superiority of Hammersmith assessment versus gold standard MRI in terms sensitivity for early prediction of DNS |
| Comparing the correlations of MRI and US scans with early prediction of DNS | 12 month | Comparing the correlations of MRI and US scans with the early prediction of DNS |
| Comparing the correlations of US scan and Hammersmith assessment | 12 month | Comparing the correlations of US scan and Hammersmith assessment with the early prediction of DNS |
| Specificity and sensitivity for all techniques MRI, US and Hammersmith | 12 month | Calculations for specificity and sensitivity would be applied for MRI, US and Hammersmith |
Countries
Saudi Arabia
Outcome results
None listed